Short Overview: Sax, MD Moderator: Marina Klein, MD, MS February 17, 2026 Although the overall incidence of The World Health Organization launches a new landmark report showing high levels of

Managing Art Options In The Setting Of Hiv Drug Resistance -

Sax, MD Moderator: Marina Klein, MD, MS February 17, 2026 Although the overall incidence of The World Health Organization launches a new landmark report showing high levels of Koren, PharD, MPH, BCPS, AAHIVP, FIDSA Adjunct Assistant Professor, Temple ...

Important details found

  • Sax, MD Moderator: Marina Klein, MD, MS February 17, 2026 Although the overall incidence of
  • The World Health Organization launches a new landmark report showing high levels of
  • Koren, PharD, MPH, BCPS, AAHIVP, FIDSA Adjunct Assistant Professor, Temple ...

Why this topic is useful

This topic is useful when readers need a quick overview first, then want to move into supporting details and related references.

Sponsored

Frequently Asked Questions

Why are related topics included?

Related topics help readers compare nearby references and understand the broader subject.

What is this page about?

This page summarizes Managing Art Options In The Setting Of Hiv Drug Resistance and connects it with related entries, references, and supporting context.

Is the information always complete?

Not always. Some topics may need verification from official or primary sources.

Visual References

Managing ART Options in the Setting of HIV Drug Resistance
The art of managing HIV resistance
What to Do Next: Use of Resistance Testing and Managing ART Failure in People With HIV
#AskTheHIVDoc: What is HIV drug resistance?
Part I:  Understanding HIV Drug Resistance
HIV-1 Drug Resistance: Resource Limited Settings | Protocol Preview
HIV Resistance: Genotyping, Archiving and Salvage therapy Part 3/3
Webinar: Addressing HIV drug resistance to protect the effectiveness of HIV treatment
Update on the interpretation and management of HIV drug resistance
WHO: Action against HIV drug resistance threat
Sponsored
View Full Details
Managing ART Options in the Setting of HIV Drug Resistance

Managing ART Options in the Setting of HIV Drug Resistance

Presenter: Paul E. Sax, MD Moderator: Marina Klein, MD, MS February 17, 2026 Although the overall incidence of

The art of managing HIV resistance

The art of managing HIV resistance

Read more details and related context about The art of managing HIV resistance.

What to Do Next: Use of Resistance Testing and Managing ART Failure in People With HIV

What to Do Next: Use of Resistance Testing and Managing ART Failure in People With HIV

Presenter: Michael S. Saag, MD Panelists: Constance A. Benson, MD, Monica Gandhi, MD, MPH, Rajesh T. Gandhi, MD, David H.

#AskTheHIVDoc: What is HIV drug resistance?

#AskTheHIVDoc: What is HIV drug resistance?

AskTheHIVDoc is a series of short explainer videos from Greater Than

Part I:  Understanding HIV Drug Resistance

Part I: Understanding HIV Drug Resistance

Read more details and related context about Part I: Understanding HIV Drug Resistance.

HIV-1 Drug Resistance: Resource Limited Settings | Protocol Preview

HIV-1 Drug Resistance: Resource Limited Settings | Protocol Preview

Read more details and related context about HIV-1 Drug Resistance: Resource Limited Settings | Protocol Preview.

HIV Resistance: Genotyping, Archiving and Salvage therapy Part 3/3

HIV Resistance: Genotyping, Archiving and Salvage therapy Part 3/3

Read more details and related context about HIV Resistance: Genotyping, Archiving and Salvage therapy Part 3/3.

Webinar: Addressing HIV drug resistance to protect the effectiveness of HIV treatment

Webinar: Addressing HIV drug resistance to protect the effectiveness of HIV treatment

Read more details and related context about Webinar: Addressing HIV drug resistance to protect the effectiveness of HIV treatment.

Update on the interpretation and management of HIV drug resistance

Update on the interpretation and management of HIV drug resistance

A Free PANCAP webinar by Dr. David E. Koren, PharD, MPH, BCPS, AAHIVP, FIDSA Adjunct Assistant Professor, Temple ...

WHO: Action against HIV drug resistance threat

WHO: Action against HIV drug resistance threat

The World Health Organization launches a new landmark report showing high levels of